Ilant Health Raises $15M to Replace Fragmented Obesity Care With AI-supported, Precision Care

• Ilant is redefining obesity care from a set of disconnected interventions into a continuous, service that delivers outcomes at scale
• The company operates as an AI-enabled healthcare services company, bringing a precision medicine approach to obesity care by continuously adapting treatment pathways to each individual over time
• Ilant delivers both clinical and financial impact by addressing the primary drivers of obesity-related healthcare costs, introducing personalized care models that deliver value and reduce unnecessary spend

NEW YORK--(BUSINESS WIRE)--Ilant Health, the value-based obesity treatment company working with employers and health plans to deliver clinical outcomes and reduce the total cost of care, announced it has raised $15 million in Series A funding, bringing its total funding to over $22M to date. The round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, as well as existing investors Celtic, LifeX, and AlphaLab.

Founded by Elina Onitskansky (formerly McKinsey and Molina Healthcare), Ilant works directly with employers and health plans to deliver comprehensive, clinician-led care for obesity and related conditions. Ilant delivers measurable clinical and financial outcomes, versus solutions focused on access or cost control, or fragmented solutions that look at obesity and weight loss in isolation from broader health.

Early results show that members achieve 15% weight loss on average — well above 5.8% reported in real-world settings - alongside measurable gains in broader biometrics and overall wellbeing, including an average of two additional mentally healthy days per month. These results highlight Ilant’s success improving outcomes in clinically meaningful ways. The company does this while managing both treatment costs and total cost of care for employers and payers, creating a uniquely compelling value proposition.

The Rise of AI-Enabled Healthcare Services and Precision Care
The company delivers these results through clinician-led care with treatment that is precision-matched to individual member needs based on clinical, behavioral, and personal data, and continuously optimized based on how each individual responds in practice. Treatment includes behavioral therapy, medication (including both GLP-1 and non-GLP-1 therapies), and surgical options as delivered in a comprehensive model that address nutrition, physical activity, and stress alongside medical care.

The approach focuses on initiating with the best treatment, and consistently enhancing outcomes over time, delivering life-changing clinical results while avoiding unnecessary or ineffective care.

Early Traction and Demand Signal Rapid growth
Ilant is already working with leading employers and healthcare partners to deliver measurable improvements in both outcomes and cost, reflecting strong demand for models that move beyond point solutions toward integrated, outcomes-based care.

“What stood out with Ilant was their precision-based, data-driven approach to obesity care, not a one-size-fits-all model centered on medication only,” said Kenneth L. Gardner, Director of Growth, Benefit Operations, SEIU 775 BENEFITS GROUP. “Ilant conducted a detailed analysis of our population and identified the members most likely to benefit clinically and financially, giving us confidence in both improved outcomes and meaningful ROI. Just as importantly, the members consistently share positive feedback about the care, support, and personalized attention they receive from the Ilant team.”

As part of this approach, in November 2025, Ilant announced direct contracting and transparent pricing solutions for obesity management medicines available through Lilly’s Employer Connect program; the company is also working with Novo Nordisk. These manufacturer contracts enable Ilant to provide transparent prices for medications with flexibility in design, giving employers greater visibility and control over one of the fastest-growing areas of healthcare spend.

Recent results from Eli Lilly and Company, reported by the Financial Times, highlight the scale and speed of demand for GLP-1 weight-loss drugs, with revenues surging as adoption accelerates. As more employers face pressure to offer coverage while managing rising pharmacy spend, the need for models and infrastructure that can bring predictability and control - while delivering outcomes and experience - has never been higher.

“Employers and health plans are facing a real dilemma right now — they are faced with either expanding access and watching pharmaceutical costs rise dramatically, or restricting access and risking rising chronic disease and cost,” said Elina Onitskansky, Founder and CEO of Ilant. “That’s not a sustainable model. If we don’t change how care is delivered, we’re just paying more for the same broken system, and we risk a crisis where both chronic disease and costs are spiraling out of control. Ilant’s model focuses on delivering real value with manageable treatment costs and clinically meaningful care that actually bends the cost curve.”

Investors see this shift as defining the next phase of obesity and cardiometabolic care.

“We believe the next generation of category-defining companies will be those that deliver outcomes as a service, not just tools or access,” said Aryeh Ganz, Founder and Managing Partner of Cornucopian Capital. “Ilant is applying that model to one of the most important and costly areas in healthcare. The company understands that the future of obesity and cardiometabolic care will not be defined by access to a single class of drugs, but by the ability to deliver the right care to the right patient at the right time. Their model aligns clinical rigor with economic value in a way that we believe will define this category over the next decade.”

About Ilant Health
Ilant Health is an obesity and cardiometabolic health company, focused on increasing access to treatment while reducing total cost of care for employers and payers through value-based care. Ilant Health provides the single front door for individuals with obesity, delivering end-to-end evidence-based solutions (bariatric surgery, medication, intense behavioral therapy) through a technology-enabled and analytics-driven obesity medicine practice. To learn more about Ilant Health, please visit their website at https://www.ilanthealth.com/.